NeuroScientific specialist hire sets stage for major Crohn’s trial

The Sydney Morning Herald - Oct 1, 2026

NeuroScientific Biopharmaceuticals has hired Southern Star Research for a phase two trial of its StemSmart Crohn’s disease therapy in Australia and the US.

Read full article

More News

The Morning Herald

The Morning Herald is a fast news provider in the United States since 2005. Fiercely independent and armed with irreverent intelligence, there’s no other place to get your news other than The Morning Herald.

NEWSLETTER